Literature DB >> 19917725

Histone deacetylase 7 and FoxA1 in estrogen-mediated repression of RPRM.

Simeen Malik1, Shiming Jiang, Jason P Garee, Eric Verdin, Adrian V Lee, Bert W O'Malley, Mao Zhang, Narasimhaswamy S Belaguli, Steffi Oesterreich.   

Abstract

Activation of estrogen receptor alpha (ERalpha) results in both induction and repression of gene transcription; while mechanistic details of estrogen induction are well described, details of repression remain largely unknown. We characterized several ERalpha-repressed targets and examined in detail the mechanism for estrogen repression of Reprimo (RPRM), a cell cycle inhibitor. Estrogen repression of RPRM is rapid and robust and requires a tripartite interaction between ERalpha, histone deacetylase 7 (HDAC7), and FoxA1. HDAC7 is the critical HDAC needed for repression of RPRM; it can bind to ERalpha and represses ERalpha's transcriptional activity--this repression does not require HDAC7's deacetylase activity. We further show that the chromatin pioneer factor FoxA1, well known for its role in estrogen induction of genes, is recruited to the RPRM promoter, is necessary for repression of RPRM, and interacts with HDAC7. Like other FoxA1 recruitment sites, the RPRM promoter is characterized by H3K4me1/me2. Estrogen treatment causes decreases in H3K4me1/me2 and release of RNA polymerase II (Pol II) from the RPRM proximal promoter. Overall, these data implicate a novel role for HDAC7 and FoxA1 in estrogen repression of RPRM, a mechanism which could potentially be generalized to many more estrogen-repressed genes and hence be important in both normal physiology and pathological processes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19917725      PMCID: PMC2798473          DOI: 10.1128/MCB.00907-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  73 in total

1.  Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase.

Authors:  R Ohki; J Nemoto; H Murasawa; E Oda; J Inazawa; N Tanaka; T Taniguchi
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

2.  FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription.

Authors:  Mathieu Lupien; Jérôme Eeckhoute; Clifford A Meyer; Qianben Wang; Yong Zhang; Wei Li; Jason S Carroll; X Shirley Liu; Myles Brown
Journal:  Cell       Date:  2008-03-21       Impact factor: 41.582

3.  Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors.

Authors:  Zeynep Madak-Erdogan; Karen J Kieser; Sung Hoon Kim; Barry Komm; John A Katzenellenbogen; Benita S Katzenellenbogen
Journal:  Mol Endocrinol       Date:  2008-07-10

4.  Inhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor alpha and Sp3 proteins.

Authors:  M Stoner; F Wang; M Wormke; T Nguyen; I Samudio; C Vyhlidal; D Marme; G Finkenzeller; S Safe
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

5.  Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer.

Authors:  S P Newman; N P Bates; D Vernimmen; M G Parker; H C Hurst
Journal:  Oncogene       Date:  2000-01-27       Impact factor: 9.867

6.  Estrogen receptor alpha represses transcription of early target genes via p300 and CtBP1.

Authors:  Fabio Stossi; Zeynep Madak-Erdogan; Benita S Katzenellenbogen
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

7.  Histone deacetylase 7 promotes PML sumoylation and is essential for PML nuclear body formation.

Authors:  Chengzhuo Gao; Chun-Chen Ho; Erin Reineke; Minh Lam; Xiwen Cheng; Kristopher J Stanya; Yu Liu; Sharmistha Chakraborty; Hsiu-Ming Shih; Hung-Ying Kao
Journal:  Mol Cell Biol       Date:  2008-07-14       Impact factor: 4.272

8.  Estrogen-mediated downregulation of CD24 in breast cancer cells.

Authors:  Benny Abraham Kaipparettu; Simeen Malik; Santhi D Konduri; Wensheng Liu; Matjaz Rokavec; Heiko van der Kuip; Reiner Hoppe; Stephanie Hammerich-Hille; Peter Fritz; Werner Schroth; Ina Abele; Gokul M Das; Steffi Oesterreich; Hiltrud Brauch
Journal:  Int J Cancer       Date:  2008-07-01       Impact factor: 7.396

9.  Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype.

Authors:  Jonna Frasor; Jeanne M Danes; Barry Komm; Ken C N Chang; C Richard Lyttle; Benita S Katzenellenbogen
Journal:  Endocrinology       Date:  2003-07-10       Impact factor: 4.736

10.  Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen.

Authors:  Antoni Hurtado; Kelly A Holmes; Timothy R Geistlinger; Iain R Hutcheson; Robert I Nicholson; Myles Brown; Jie Jiang; William J Howat; Simak Ali; Jason S Carroll
Journal:  Nature       Date:  2008-11-12       Impact factor: 49.962

View more
  43 in total

1.  Small molecule JQ1 promotes prostate cancer invasion via BET-independent inactivation of FOXA1.

Authors:  Leiming Wang; Mafei Xu; Chung-Yang Kao; Sophia Y Tsai; Ming-Jer Tsai
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

2.  Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers.

Authors:  Aurélien A Sérandour; Stéphane Avner; Frédéric Percevault; Florence Demay; Maud Bizot; Céline Lucchetti-Miganeh; Frédérique Barloy-Hubler; Myles Brown; Mathieu Lupien; Raphaël Métivier; Gilles Salbert; Jérôme Eeckhoute
Journal:  Genome Res       Date:  2011-01-13       Impact factor: 9.043

Review 3.  Histone deacetylases and cancer.

Authors:  Bruna Barneda-Zahonero; Maribel Parra
Journal:  Mol Oncol       Date:  2012-08-27       Impact factor: 6.603

Review 4.  Metal-dependent Deacetylases: Cancer and Epigenetic Regulators.

Authors:  Jeffrey E López; Eric D Sullivan; Carol A Fierke
Journal:  ACS Chem Biol       Date:  2016-03-18       Impact factor: 5.100

5.  Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6.

Authors:  Noritaka Yamaguchi; Yuji Nakayama; Naoto Yamaguchi
Journal:  J Biol Chem       Date:  2017-03-07       Impact factor: 5.157

Review 6.  FOXA1: a transcription factor with parallel functions in development and cancer.

Authors:  Gina M Bernardo; Ruth A Keri
Journal:  Biosci Rep       Date:  2012-04-01       Impact factor: 3.840

Review 7.  Tumor suppressor maspin as a rheostat in HDAC regulation to achieve the fine-tuning of epithelial homeostasis.

Authors:  Alexander Kaplun; Sijana Dzinic; M Bernardo; Shijie Sheng
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2012       Impact factor: 1.807

Review 8.  New and emerging HDAC inhibitors for cancer treatment.

Authors:  Alison C West; Ricky W Johnstone
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

9.  HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells.

Authors:  Corrado Caslini; Sunhwa Hong; Yuguang J Ban; Xi S Chen; Tan A Ince
Journal:  Oncogene       Date:  2019-08-02       Impact factor: 9.867

10.  Androgen receptor-independent function of FoxA1 in prostate cancer metastasis.

Authors:  Hong-Jian Jin; Jonathan C Zhao; Irene Ogden; Raymond C Bergan; Jindan Yu
Journal:  Cancer Res       Date:  2013-03-28       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.